Unitree Robotics has shed $35 billion in market capitalization since its August 2026 debut on the Shanghai Stock Exchange, with shares closing at 53% below the IPO price as of September 9. The Hangzhou-based manufacturer, known for its sub-$2,000 quadruped robots and recently launched humanoid platform, now carries a $31 billion valuation, a figure that still places it among the most valuable pure-play robotics companies globally but represents a sharp rebuke from retail investors who drove the initial frenzy. Trading volume in the first week reached 8.2 million shares daily. Volume has since fallen to 1.3 million shares, suggesting the initial cohort of momentum buyers has rotated out.
The company raised $4.2 billion in the IPO, pricing shares at the top of the range and allocating 60% of the offering to domestic retail investors through the Shanghai exchange's stratified system. That structure, designed to give mainland Chinese households access to high-growth technology names, also concentrates volatility. Unitree's founder and CEO, Wang Xingxing, retained a 42% stake post-offering and has not sold shares. The IPO prospectus disclosed 2025 revenue of $890 million, primarily from sales of the Go2 and B2 quadruped models to enterprise customers in logistics, inspection, and public safety. The company reported operating losses of $120 million for the year, driven by R&D expenditures on its G1 humanoid platform and international distribution infrastructure. Underwriters included CICC and Haitong Securities, both of which issued bullish initiation reports in late August projecting the company would reach profitability by Q3 2027.
The selloff accelerated after a September 3 report from Bernstein questioning Unitree's margin assumptions for the G1 humanoid, which the company began shipping in limited quantities to research institutions in July 2026. Bernstein analyst Toni Sacconaghi estimated the G1 carried a bill of materials cost of $14,000 but retailed at $16,000, leaving little room for distribution, warranty, and support expenses. Unitree has not disclosed G1 unit margins. The report also noted that 68% of Unitree's 2025 revenue came from Chinese customers, with only 11% from North America despite the company's stated ambition to compete directly with Boston Dynamics and Agility Robotics in U.S. warehouse automation. Export restrictions on certain actuator components, imposed by Beijing in April 2026, have further complicated the company's ability to scale internationally. Shares fell 9% the day the Bernstein report published and have not recovered.
Broader weakness in Chinese technology stocks has compounded Unitree's troubles. The Shanghai Stock Exchange Composite Index is down 14% from its July peak, dragged lower by concerns over slowing domestic consumption and tighter credit conditions for private enterprises. At least three other robotics-related IPOs scheduled for Q4 2026, including agricultural drone maker XAG and collaborative robot manufacturer Elephant Robotics, have postponed listings. Investors are now scrutinizing path-to-profitability timelines more closely than during the exuberant first half of the year. For Unitree, the challenge is demonstrating that its low-cost manufacturing advantage, rooted in vertically integrated motor and controller production, translates to sustainable gross margins above 30% as the company scales humanoid production. The G1 uses 23 custom actuators, each requiring precision machining and quality control processes that do not lend themselves to the rapid cost reduction curves seen in consumer electronics.
What to Watch: Unitree is scheduled to report Q3 2026 earnings in late October, which will include the first full quarter of G1 shipments and provide clarity on humanoid unit economics. Watch for any announcements regarding partnerships with U.S. systems integrators or logistics providers, which would signal progress on international expansion despite export control headwinds. Shanghai Stock Exchange filings will reveal whether insiders or early venture investors sell shares when lockup restrictions expire in February 2027. Finally, track pricing moves on the G1; any reduction below $16,000 would confirm margin pressure and likely trigger another leg down in the stock.
